Media Centre
Latest press releases
-
Imfinzi is the first immunotherapy to demonstrate significant overall survival benefit in unresectable, Stage III lung cancer
-
Bydureon receives positive EU CHMP opinion for EXSCEL cardiovascular outcomes data
-
European Commission approves Imfinzi for locally-advanced, unresectable NSCLC
-
Farxiga achieved a positive result in the Phase III DECLARE-TIMI 58 trial, a large cardiovascular outcomes trial in 17,000 patients with type-2 diabetes
-
AstraZeneca presents further data showing the interconnectivity between cardiovascular and renal risks in diabetes at EASD 2018
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Karen Birmingham
Director Global Science Media
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Gonzalo Viña
Director Global Media Relations
Jacob Lund
Director External Communications, Sweden
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
